90 related articles for article (PubMed ID: 23298323)
1. In vivo brain microdialysis as a formulation-screening tool for a poorly soluble centrally acting drug.
Bommana MM; Kirthivasan B; Shikhar A; Gupta SS; Squillante E
Drug Dev Ind Pharm; 2014 Jan; 40(1):74-9. PubMed ID: 23298323
[TBL] [Abstract][Full Text] [Related]
2. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
3. Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer.
Yamashita H; Sun CC
Pharm Res; 2019 Apr; 36(6):90. PubMed ID: 31016440
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Biopharmaceutical Performance of Supersaturating Formulations of Carbamazepine in Rats Using Physiologically Based Pharmacokinetic Modeling.
Thakore SD; Thakur PS; Shete G; Gangwal R; Narang AS; Sangamwar AT; Bansal AK
AAPS PharmSciTech; 2019 Apr; 20(5):179. PubMed ID: 31041552
[TBL] [Abstract][Full Text] [Related]
6. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
7. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
Tayel SA; Soliman II; Louis D
Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
[TBL] [Abstract][Full Text] [Related]
8. Role of humic acid on oral drug delivery of an antiepileptic drug.
Mirza MA; Agarwal SP; Rahman MA; Rauf A; Ahmad N; Alam A; Iqbal Z
Drug Dev Ind Pharm; 2011 Mar; 37(3):310-9. PubMed ID: 20815797
[TBL] [Abstract][Full Text] [Related]
9. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer.
Yamashita H; Sun CC
Pharm Res; 2017 Dec; 35(1):4. PubMed ID: 29288433
[TBL] [Abstract][Full Text] [Related]
10. Transformations between Co-Amorphous and Co-Crystal Systems and Their Influence on the Formation and Physical Stability of Co-Amorphous Systems.
Wu W; Wang Y; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2019 Mar; 16(3):1294-1304. PubMed ID: 30624075
[TBL] [Abstract][Full Text] [Related]
11. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
[TBL] [Abstract][Full Text] [Related]
12. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
Van Belle K; Sarre S; Ebinger G; Michotte Y
J Pharmacol Exp Ther; 1995 Mar; 272(3):1217-22. PubMed ID: 7891336
[TBL] [Abstract][Full Text] [Related]
13. Variability in commercial carbamazepine samples--impact on drug release.
Flicker F; Eberle VA; Betz G
Int J Pharm; 2011 May; 410(1-2):99-106. PubMed ID: 21435386
[TBL] [Abstract][Full Text] [Related]
14. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
[TBL] [Abstract][Full Text] [Related]
15. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
Patel NV; Chotai NP; Patel MP
Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
[TBL] [Abstract][Full Text] [Related]
16. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
[TBL] [Abstract][Full Text] [Related]
17. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291
[TBL] [Abstract][Full Text] [Related]
18. Anti-solvent co-crystallization of carbamazepine and saccharin.
Wang IC; Lee MJ; Sim SJ; Kim WS; Chun NH; Choi GJ
Int J Pharm; 2013 Jun; 450(1-2):311-22. PubMed ID: 23598078
[TBL] [Abstract][Full Text] [Related]
19. Viability and permeability across Caco-2 cells of CBZ solubilized in fully dilutable microemulsions.
Kogan A; Kesselman E; Danino D; Aserin A; Garti N
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):1-12. PubMed ID: 18599273
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
